You are here

Modeling disease in swine by transplantation of gene targeted germ cells.

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM108150-01A1
Agency Tracking Number: R43GM108150
Amount: $375,429.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIGMS
Solicitation Number: PA13-234
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1246 University Ave W
SAINT PAUL, MN 55104-4125
United States
DUNS: 829874523
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 SCOTT FAHRENKRUG
 (612) 432-4265
 scott@recombinetics.com
Business Contact
 CARLSON DAN
Phone: (612) 432-4265
Email: dan@recombinetics.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): Swine models of human disease will become increasingly important for the development of relevant, preclinical therapeutics. However, the creation of swine congenital disease models is plagued by inefficiencies related to animal development and reproduction. The contemporary method for development relies on somatic cell nuclear transfer (SCNT) of genetically modified primary cells. While effective for the development of founders, cloning is not suitable for the creation of enough animals to meet the biomedical research market, requiring instead a production breeding program. The phenotype of affected animals may be inconsistent with long-term viability and/or sexual reproduction, so disease alleles need to be propagated asheterozygotes. However, a breeding program based on heterozygotes is slow and results in the only 1/4 of the production being affected offspring, dramatically increasing the cost of swine model production. As a solution we propose to develop and pro

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government